Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 342 of 1,261
  1. US 11014902

    MYC G-quadruplex stabilizing small molecules and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 25, 2021 · Expires May 20, 2041

    granted
  2. US 11016009

    Method for isolating extracellular vesicles using aqueous two-phase system

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 25, 2021 · Expires May 20, 2041

    granted
  3. US 11014892

    5HT1F receptor agonists and mitochondrial biogenesis

    United States Government as represented by the Department of Veterans Affairs · Granted May 25, 2021 · Expires May 20, 2041

    granted
  4. US 11013791

    NYVAC-based plasmodium malaria vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted May 25, 2021 · Expires May 20, 2041

    granted
  5. US 11013808

    Clinical formulations

    Astellas Institute for Regenerative Medicine · Granted May 25, 2021 · Expires May 20, 2041

    granted
  6. US 11013809

    Sustained delivery formulations of risperidone compound

    Indivior UK Limited · Granted May 25, 2021 · Expires May 20, 2041

    granted
  7. US 11013806

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  8. US 11013782

    Methods of treating chronic disorders with complement inhibitors

    Apellis Pharmaceuticals, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  9. US 11013770

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  10. US 11013787

    Sustained release formulation of interleukin-10 for wound treatment and related methods

    THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER · Granted May 25, 2021 · Expires May 20, 2041

    granted
  11. US 11013785

    Activin receptor type IIA variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  12. US 11013774

    Methods of heat inactivation of adenovirus

    Ultragenyx Pharmaceutical Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  13. US 11013743

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  14. US 11013740

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  15. US 11013705

    Methods and compositions for supporting renal health

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  16. US 11013707

    Administration of oral methyldopa

    The Regents of the University of Colorado, a Body Corporate · Granted May 25, 2021 · Expires May 20, 2041

    granted
  17. US 11013726

    Substituted pyridinone-containing trycyclic compounds, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted May 25, 2021 · Expires May 20, 2041

    granted
  18. US 11013754

    Compositions and methods for treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 25, 2021 · Expires May 20, 2041

    granted
  19. US 11013220

    Humanized dipeptidyl-peptidase IV (DPP4) animals

    REGENERON PHARMACEUTICALS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  20. US 11013704

    Compounds supports hematopoietic stem cells and red blood cells

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  21. US 11016093

    Disease-associated antigens and methods of use thereof

    The Regents of the University of California · Granted May 25, 2021 · Expires May 20, 2041

    granted
  22. US 11007163

    Glutarate compounds for treating ischemia-reperfusion injuries

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  23. US 11007157

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  24. US 11008590

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.